Shariah compliance overview
HalalTG Therapeutics, Inc. (TGTX) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About TG Therapeutics, Inc.
Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions.
TG Therapeutics, Inc. (TGTX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.00% (limit 5%), interest-bearing debt is 6.17% (limit 30%) and interest-bearing securities and assets are 3.45% (limit 30%).
- Business Activity
- 0.00%Limit 5%Pass
- Interest-bearing debt
- 6.17%Limit 30%Pass
- Interest-bearing securities and assets
- 3.45%Limit 30%Pass
- Dividend purification
- 0.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about TG Therapeutics, Inc. (TGTX). Current Akinda screening label: Halal.
